PPARγ-IN-3

PPARγ-IN-3 (9ga) is a potent, orally active PPARγ inhibitor that reduces triglyceride accumulation in vitro with low cytotoxicity. In diet-induced obesity models, it mitigates body weight gain, decreases hepatic and blood lipid levels, and reduces fat and liver mass, making it a valuable research tool for metabolic disease studies.